Andrew D. Leavitt
- Hematology top 5%
- Platelet Disorders and Treatments 1
- Internal Medicine top 5%
-
- Virus-based gene therapy research 1
- Infectious Diseases top 10%
-
- Cytokine Signaling Pathways and Interactions 1
- CAR-T cell therapy research 1
-
- Blood properties and coagulation 1
-
- RNA modifications and cancer 1
- Pluripotent Stem Cells Research 1
- CRISPR and Genetic Engineering 1
- Co-authors
- D. SayahMark B. HeadleyEmily ThorntonEmmanuelle PasseguéAxelle CaudrillierGuadalupe Ortiz-MuñozFengchun LiuBeñat Mallavia
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Andrew D. Leavitt
8 papers receiving 839 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 322
- Internal Medicine 71
- Immunology 176
- Genetics 75
- Infectious Diseases 116
Countries citing papers authored by Andrew D. Leavitt
This map shows the geographic impact of Andrew D. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Leavitt more than expected).
Fields of papers citing papers by Andrew D. Leavitt
This network shows the impact of papers produced by Andrew D. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Leavitt. The network helps show where Andrew D. Leavitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew D. Leavitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 2 | |
| 3 | 2023 | 18 | |
| 4 | 2022 | 4 | |
| 5 | The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitorsbreakdown → | 2017 | 767 |
| 6 | 2013 | 6 | |
| 7 | 2012 | 30 | |
| 8 | 2007 | 21 |
About Andrew D. Leavitt
Andrew D. Leavitt is a scholar working on Hematology, Internal Medicine and Genetics, having authored 8 papers that have together received 854 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (1 paper), Blood properties and coagulation (1 paper), RNA modifications and cancer (1 paper), Pluripotent Stem Cells Research (1 paper), Virus-based gene therapy research (1 paper), CRISPR and Genetic Engineering (1 paper), CAR-T cell therapy research (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Hematology (322 citations), Internal Medicine (71 citations) and Immunology (176 citations). Andrew D. Leavitt has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include D. Sayah, Mark B. Headley, Emily Thornton, Emmanuelle Passegué, Axelle Caudrillier, Guadalupe Ortiz-Muñoz, Fengchun Liu, Beñat Mallavia, Matthew F. Krummel and Mark R. Looney. Their work appears in journals such as Nature, Blood and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.